Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 3521481, 6 pages
https://doi.org/10.1155/2017/3521481
Research Article

In Vivo Murine Model of Leukemia Cell-Induced Spinal Bone Destruction

1Institute of Molecular Medicine, Health Science Center, Shenzhen University, Shenzhen 518060, China
2Vaccine Research Institute of Sun Yat-sen University, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
3Department of Spine Surgery and Joint Surgery, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China

Correspondence should be addressed to Jia-Jie Chen; nc.ude.uzs@jjnehc and Gang Chang; nc.ude.uzs@gnaggnahc

Received 23 April 2017; Revised 6 August 2017; Accepted 15 August 2017; Published 28 September 2017

Academic Editor: Peter J. Oefner

Copyright © 2017 Jia-Jie Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Prick, G. de Haan, A. R. Green, and D. G. Kent, “Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasms,” Experimental Hematology, vol. 42, no. 10, pp. 841–851, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Shah, S. Parikh, and R. Rawal, “Tyrosine kinase inhibitors in Ph+ chronic myeloid leukemia therapy: a review,” Asian Pacific Journal of Cancer Prevention, vol. 17, no. 7, pp. 3025–3033, 2016. View at Google Scholar · View at Scopus
  3. J.-Q. Mi, J.-M. Li, Z.-X. Shen, S.-J. Chen, and Z. Chen, “How to manage acute promyelocytic leukemia,” Leukemia, vol. 26, no. 8, pp. 1743–1751, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. K. D. Miller, R. L. Siegel, and C. C. Lin, “Cancer treatment and survivorship statistics, 2016,” CA Cancer Journal for Clinicians, vol. 66, no. 4, pp. 271–289, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Chambers, P. Truong, K. J. Kallail, and W. Palko, “Extensive bone marrow necrosis and osteolytic lesions in a case of acute myeloid leukemia transformed from polycythemia vera,” Cureus, vol. 8, no. 6, article e639, 2016. View at Publisher · View at Google Scholar
  6. T. Badar, A. Shetty, C. Bueso-Ramos et al., “Bone marrow necrosis in acute leukemia: clinical characteristic and outcome,” American Journal of Hematology, vol. 90, no. 9, pp. 769–773, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Jurisic, T. Terzic, S. Pavlovic, N. Colovic, and M. Colovic, “Elevated TNF-α and LDH without parathormone disturbance is associated with diffuse osteolytic lesions in leukemic transformation of myelofibrosis,” Pathology Research and Practice, vol. 204, no. 2, pp. 129–132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. C. S. P. Lima, J. V. Pinto Neto, M. L. Da Cunha, J. Vassallo, I. A. Cardinalli, and C. A. De Souza, “Osteolytic lesions as a presenting sign of acute myeloid leukemia,” Haematologia, vol. 30, no. 4, pp. 325–331, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. O. Brumariu, I. Miron, I. Cernahoschi et al., “Osteoarticular changes in childhood leukemia, lymphoma and neuroblastoma,” Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi, vol. 104, no. 4, pp. 67–69, 2000. View at Google Scholar
  10. S. Tsukamoto, S. Ota, C. Ohwada et al., “Extramedullary blast crisis of chronic myelogenous leukemia as an initial presentation,” Leukemia Research Reports, vol. 2, no. 2, pp. 67–69, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. S. M. Crain, A. M. Choudhury, Z. Molnar, and V. R. Jablokow, “Destructive osteolytic bone lesions in chronic granulocytic leukemia,” IMJ: Illinois Medical Journal, vol. 162, no. 3, pp. 213–217, 1982. View at Google Scholar · View at Scopus
  12. N. Geetha, K. P. Sreelesh, M. J. Priya, V. S. Lali, and N. Rekha, “Osteolytic bone lesions—a rare presentation of AML M6,” Mediterranean Journal of Hematology and Infectious Diseases, vol. 7, no. 1, Article ID e2015017, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Harir, C. Pecquet, M. Kerenyi et al., “Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias,” Blood, vol. 109, no. 4, pp. 1678–1686, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Moriggl, V. Sexl, L. Kenner et al., “Stat5 tetramer formation is associated with leukemogenesis,” Cancer Cell, vol. 7, no. 1, pp. 87–99, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. R. M. Lemoli, A. Fortuna, A. Tafuri et al., “Interleukin-9 stimulates the proliferation of human myeloid leukemic cells,” Blood, vol. 87, no. 9, pp. 3852–3859, 1996. View at Google Scholar · View at Scopus
  16. K. Al Zaid Siddiquee and J. Turkson, “STAT3 as a target for inducing apoptosis in solid and hematological tumors,” Cell Research, vol. 18, no. 2, pp. 254–267, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Yu, M. Kortylewski, and D. Pardoll, “Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment,” Nature Reviews Immunology, vol. 7, no. 1, pp. 41–51, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Ye, N. Wolff, L. Li, S. Zhang, and R. L. Ilaria Jr., “STAT5 signaling is required for the efficient induction and maintenance of CML in mice,” Blood, vol. 107, no. 12, pp. 4917–4925, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Walz, W. Ahmed, K. Lazarides et al., “Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2 V617F in mice,” Blood, vol. 119, no. 15, pp. 3550–3560, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. R. S. Lewis and A. C. Ward, “Stat5 as a diagnostic marker for leukemia,” Expert Review of Molecular Diagnostics, vol. 8, no. 1, pp. 73–82, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. A. R. Hayman, “Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy,” Autoimmunity, vol. 41, no. 3, pp. 218–223, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. G. J. Cook and T. S. Pardee, “Animal models of leukemia: any closer to the real thing?” Cancer and Metastasis Reviews, vol. 32, no. 1-2, pp. 63–76, 2013. View at Publisher · View at Google Scholar · View at Scopus